Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionLegacy Financial Advisors, Inc.
Latest Disclosed Ownership3,144 shares
Latest Disclosed Value $ 1,403,703
Legacy Financial Advisors, Inc. reports 5.68% increase in ownership of VRTX / Vertex Pharmaceuticals Incorporated

On April 30, 2026 - Legacy Financial Advisors, Inc. filed a 13F-HR form disclosing ownership of 3,144 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $1,403,922 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 4, 2026 disclosing 2,975 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 5.68% during the quarter. The current value of the position is $1,404,834 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 3,144 169 5.68 1,404 4.08 0.1963
2026-02-04 2025-12-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 2,975 49 1.67 1,349 17.73 0.1865
2025-11-10 2025-09-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 2,926 -55 -1.85 1,146 -13.72 0.1579
2025-08-07 2025-06-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 2,981 -105 -3.40 1,327 -11.30 0.2073
2025-05-14 2025-03-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 3,086 534 20.92 1,496 45.67 0.2502
2025-02-13 2024-12-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 2,552 104 4.25 1,028 -9.75 0.1699
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 2,448 25 1.03 1,139 0.26 0.1912
2024-08-13 2024-06-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 2,423 117 5.07 1,136 17.86 0.2022
2024-05-14 2024-03-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 2,306 147 6.81 964 9.68 0.1727
2024-02-13 2023-12-31 13F/A-1 VERTEX PHARMACEUTICALS IN Stock 92532F100 2,159 232 12.04 878 31.04 0.1687
2024-02-06 2023-12-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 2,159 232 878 0.1692
2023-11-13 2023-09-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 1,927 376 24.24 670 22.94 0.1341
2023-08-08 2023-06-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 1,551 163 11.74 546 24.71 0.1019
2023-05-03 2023-03-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 1,388 92 7.10 437 16.84 0.0894
2023-02-06 2022-12-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 1,296 26 2.05 374 1.63 0.0806
2022-11-09 2022-09-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 1,270 116 10.05 368 13.23 0.0880
2022-08-08 2022-06-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 1,154 170 17.28 325 26.46 0.0808
2022-05-04 2022-03-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 984 984 257 0.0578
2019-08-07 2019-06-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 0 -149 -100.00 0 -100.00
2019-05-14 2019-03-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 149 23 18.25 27 28.57 0.0091
2019-01-16 2018-12-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 126 116 1,160.00 21 2,000.00 0.0081
2018-10-30 2018-09-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 10 0 0.00 1 -50.00 0.0004
2018-07-17 2018-06-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 10 -43 -81.13 2 -75.00 0.0008
2018-04-12 2018-03-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 53 48 960.00 8 0.0032
2018-02-09 2017-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 5 5 0 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.